Ivarmacitinib improves patient-reported outcomes across multiple domains in patients with active ankylosing spondylitis: a <i>post hoc</i> analysis of a phase II/III trial. [PDF]
Front PharmacolXu X +5 more
europepmc +1 more source
Correlation between BASDAI and ASDAS to evaluate the activity of patients with spondyloarthritis [PDF]
, 2018 Saadia Ait malek +4 more
openaire +1 more source
Correlation Between Serum Procalcitonin and Disease Activity Score in Patients with Ankylosing Spondylitis That Have Hip Involvement. [PDF]
Int J Gen MedLiang X, Deng B.
europepmc +1 more source
THU0665 Can one give up basdai in favor of asdas in monitoring spondyloarthritis patients on biologics? [PDF]
, 2017 Cristian Cobilinschi +2 more
openalex +1 more source
Use of nonsteroidal anti-inflammatory drugs in patients with axial spondyloarthritis receiving biotherapy and associated factors: a prospective cohort study. [PDF]
BMC RheumatolCharoui C +6 more
europepmc +1 more source
AB0731 Overcoming the problems of untranslatability: a mobile phone application in the example of turkish version of basdai [PDF]
, 2017 Y Özmen +12 more
openalex +1 more source
Real-World Effectiveness and Safety of Upadacitinib in Tumor Necrosis FactorInhibitor Refractory Axial Spondyloarthritis: 52-Week Outcomes from a Single-Center Cohort. [PDF]
Arch RheumatolBakay U, İzci Duran T.
europepmc +1 more source
Can Whole-Body Cryotherapy with Subsequent Kinesiotherapy Procedures in Closed Type Cryogenic Chamber Improve BASDAI, BASFI, and Some Spine Mobility Parameters and Decrease Pain Intensity in Patients with Ankylosing Spondylitis? [PDF]
, 2015 Agata Stanek +5 more
openalex +1 more source
Efficacy of Telerehabilitation for Ankylosing Spondylitis: A Case Report. [PDF]
CureusNakamura K, Tozawa R.
europepmc +1 more source